Skip to main content

Advertisement

SpringerLink
Log in

Role of Traditional Chinese Herbal Medicines in Functional Gastrointestinal and Motility Disorders

  • Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao and A Sharma, Section Editors))
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Traditional Chinese medicine (TCM) has been in use for thousands of years in Asian countries and is rapidly gaining popularity in the Western world. Among different forms of TCM, the traditional Chinese herbal therapy and acupuncture are the most popular modalities. Here, we review the fundamentals of TCMs for clinicians practicing in the West and will also detail the evidence-based utility of Chinese herbal medicine in the management of functional gastrointestinal disorders (FGIDs).

Recent Findings

In the recent decades, the popularity and usage of traditional Chinese herbal medicine in FGIDs is increasing in the West. TCMs are commonly utilized by many patients with FGIDs as the conventional therapies do have limitations such as cost, inadequate symptom control and adverse effects. The unfamiliarity of TCM philosophy among clinicians in the West, and shortage of traditional Chinese herbalists remain.

Summary

The philosophy of TCM is complex and entirely different from the Western medical concepts and is difficult to understand for a clinician trained in the West. Further traditional Chinese herbal therapies are often viewed skeptically by the clinicians in the West for various reasons such as lack of scientific rigor, inconsistencies in the constituents of herbal products, and also concerns due to adverse herb effects. Future clinical trials in FGIDs should focus on herb product quality, herb-drug interactions, and standardized criteria for diagnosis and management outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Drossman DA, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–61.

    Article  PubMed  Google Scholar 

  2. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262–1279. e1262.

  3. Aziz I, Whitehead WE, Palsson OS, Törnblom H, Simrén M. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Rev Gastroenterol Hepatol. 2020;14(1):39–46.

    Article  PubMed  CAS  Google Scholar 

  4. Fikree A, Byrne P. Management of functional gastrointestinal disorders. Clin Med. 2021;21(1):44.

    Article  Google Scholar 

  5. Tait C, Sayuk GS. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions. European Journal of Internal Medicine. 2021.

  6. Xiao H-T, Zhong L, Tsang S-W, Lin Z-S, Bian Z-X. Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings. Am J Chin Med. 2015;43(01):1–23.

    Article  PubMed  Google Scholar 

  7. Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Official journal of the American College of Gastroenterology| ACG. 2021;116(1):17–44.

  8. Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214–40.

    Article  PubMed  Google Scholar 

  9. Zhong LL, Cheng C-w, Kun W, et al. Efficacy of MaZiRenWan, a Chinese herbal medicine, in patients with functional constipation in a randomized controlled trial. Clinical Gastroenterology and Hepatology. 2019;17(7):1303–1310. e1318.

  10. Zhong LL, Zheng G, Da Ge L, et al. Chinese herbal medicine for constipation: zheng-based associations among herbs, formulae, proprietary medicines, and herb–drug interactions. Chinese Medicine. 2016;11(1):1–11.

    Article  CAS  Google Scholar 

  11. Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160(1):99–114. e113.

  12. Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Official journal of the American College of Gastroenterology| ACG. 2018;113(1):86–96.

  13. Acker BW, Cash BD. Medicinal foods for functional GI disorders. Curr Gastroenterol Rep. 2017;19(12):62.

    Article  PubMed  Google Scholar 

  14. Magge SS, Wolf JL. Complementary and alternative medicine and mind–body therapies for treatment of irritable bowel syndrome in women. Women’s Health. 2013;9(6):557–67.

    CAS  PubMed  Google Scholar 

  15. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children; United States, 2007. 2008.

  16. Kemppainen LM, Kemppainen TT, Reippainen JA, Salmenniemi ST, Vuolanto PH. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scandinavian journal of public health. 2018;46(4):448–55.

    Article  PubMed  Google Scholar 

  17. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280(18):1569–75.

    Article  CAS  PubMed  Google Scholar 

  18. Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43(6):541.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Available at URL. https://www.who.int/global_health_histories/seminars/Dr_Zhangs_Presentation_GHHSeminar_86.pdf. Accessed 8.2.2021.

  20. Available at URL. https://www.who.int/publications/i/item/9789241506096. Accessed August 5, 2021.

  21. Jin LL, Zheng J, Honarvar NM, Chen X. Traditional Chinese Medicine in the United States: Current state, regulations, challenges, and the way forward. In: World Scientific; 2020. Available at URL. https://www.worldscientific.com/doi/abs/https://doi.org/10.1142/S2575900020100023

  22. Fung FY, Linn YC. Developing traditional Chinese medicine in the era of evidence-based medicine: current evidences and challenges. Evidence-Based Complementary and Alternative Medicine. 2015;2015.

  23. Zhou X, Li C-G, Chang D, Bensoussan A. Current status and major challenges to the safety and efficacy presented by Chinese herbal medicine. Medicines. 2019;6(1):14. This article reviewed the safety and efficacy of Chinese herbal medicine.

  24. Available at URL. https://www.nccih.nih.gov/health/traditional-chinese-medicine-what-you-need-to-know. Accessed 8.2.2021.

  25. Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol: WJG. 2015;21(15):4466.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Leung L. Traditional Chinese Medicine—a beginner's guide. InnovAiT 2010. Available at URL https://doi.org/10.1093/innovait/inq115. Accessed 8.2.2021.

  27. Lam WC, Lyu A, Bian Z. ICD-11: impact on traditional Chinese medicine and world healthcare systems. Pharmaceutical medicine. 2019;33(5):373–7.

    Article  CAS  PubMed  Google Scholar 

  28. Marshall AC. Traditional Chinese medicine and clinical pharmacology. Drug discovery and evaluation: Methods in Clinical Pharmacology. 2020:455–482. This review details the basics of traditional Chinese medicine methods and elaborates herbal formulations, drug-herb interactions, and herbal toxicity.

  29. Gwee KA, Holtmann G, Tack J, et al. Herbal medicines in functional dyspepsia—Untapped opportunities not without risks. Neurogastroenterology & Motility. 2021;33(2):e14044. This review described the herbal medications in functional dyspepsia and their associated risks.

  30. Wang J, Xu C, Wong YK, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering. 2019;5(1):32–9.

    Article  CAS  Google Scholar 

  31. Available at URL. https://www.nobelprize.org/prizes/medicine/2015/press-release. Accessed 8.2.2021.

  32. Cyranoski D. Why Chinese medicine is heading for clinics around the world. Nature. 2018;561(7724):448–448.

    Article  CAS  PubMed  Google Scholar 

  33. De Bortoli N, Tolone S, Frazzoni M, et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol. 2018;31(6):639.

    PubMed  PubMed Central  Google Scholar 

  34. Keller J, Bassotti G, Clarke J, et al. Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol. 2018;15(5):291–308.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Tang J-L, Liu B-Y, Ma K-W. Traditional chinese medicine. The Lancet. 2008;372(9654):1938–40.

    Article  Google Scholar 

  36. Li Q, Yang G-Y, Liu J-P. Syndrome differentiation in Chinese herbal medicine for irritable bowel syndrome: a literature review of randomized trials. Evidence-Based Complementary and Alternative Medicine. 2013;2013.

  37. Yue S-J, Wang W-X, Yu J-G, et al. Gut microbiota modulation with traditional Chinese medicine: a system biology-driven approach. Pharmacological Research. 2019;148:104453.

  38. Matos LC, Machado JP, Monteiro FJ, Greten HJ. Can Traditional Chinese Medicine Diagnosis Be Parameterized and Standardized? A Narrative Review. Paper presented at: Healthcare2021.

  39. Yuan R, Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther. 2000;86(2):191–8.

    Article  CAS  PubMed  Google Scholar 

  40. Ji L, Fan Y, Li L, Bai H, Weng L, Zhao P. Efficacy and safety of Chinese herbal compound in the treatment of functional constipation: A protocol for systematic review and meta-analysis. Medicine. 2020;99(39).

  41. Li C-Y, Li S-C. Treatment of irritable bowel syndrome in China: a review. World J Gastroenterol: WJG. 2015;21(8):2315.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Legge D. Yin and yang surfaces: an evolutionary perspective. J Acupunct Meridian Stud. 2014;7(6):281–90.

    Article  PubMed  Google Scholar 

  43. Schnorrenberger CC. Anatomical roots of acupuncture and Chinese medicine. Schweizerische Zeitschrift für Ganzheitsmedizin/Swiss Journal of Integrative Medicine. 2013;25(2):110–8.

    Article  Google Scholar 

  44. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2012.

  45. Tang S-q, Wang Y-l, Xie Z-y, et al. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine. 2021;19(3):274–81.

    Article  PubMed  Google Scholar 

  46. Zhang S, Wang H, Li Q. Chinese consensus on diagnosis and treatment of functional dyspepsia. Chin J Integr Tradit West Med Dig. 2010;30:533–7.

    Google Scholar 

  47. Xiao Y, Liu Y-y, Yu K-q, Ouyang M-z, Luo R, Zhao X-s. Chinese herbal medicine liu jun zi tang and xiang sha liu jun zi tang for functional dyspepsia: meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2012;2012.

  48. Yao F, Zhang Y, Kuang X, et al. Effectiveness and safety of moxibustion on constipation: a systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2020;2020. This meta-analysis demonsterated that moxibustion safety and efficacy in the management of constipation.

  49. Zhong LL, Cheng CW, Chan Y, et al. Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial. Trials. 2013;14(1):1–9.

    Article  Google Scholar 

  50. Qiao L, Wang L-J, Wang Y, Chen Y, Zhang H-L, Zhang S-C. A Randomized, Double-Blind, and Placebo-Controlled Trial of Chinese Herbal Medicine in the Treatment of Childhood Constipation. Clinical and Translational Gastroenterology. 2021;12(5).

  51. Liu T, Wang N, Zhang L, Zhong L. Chinese herbal medicine for functional abdominal pain syndrome: from clinical findings to basic understandings. Evidence-Based Complementary and Alternative Medicine. 2016;2016.

  52. Zhang R, Gao X, Bai H, Ning K. Traditional Chinese Medicine and gut microbiome: their respective and concert effects on healthcare. Front Pharmacol. 2020;11:538.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Lee B-W, Cho H-W, Hwang E-H, Heo I, Shin B-C, Hwang M-S. Analysis of prescription frequency of herbs in traditional Korean medicine hospital using electronic medical records. The Journal of Korean Medicine. 2019;40(4):29–40.

    Article  Google Scholar 

  54. Zhao M, Chen Y, Wang C, et al. Systems pharmacology dissection of multi-scale mechanisms of action of Huo-Xiang-Zheng-Qi formula for the treatment of gastrointestinal diseases. Front Pharmacol. 2019;9:1448.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998;280(18):1585–9.

    Article  CAS  PubMed  Google Scholar 

  56. Shih Y-S, Tsai C-H, Li T-C, et al. The effect of Xiang-Sha-Liu-Jun-Zi tang (XSLJZT) on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Ethnopharmacology. 2019;238:111889.

  57. Chen M, Qin D, Huang SL, Tang TC, Zheng H. Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta‐analysis. Neurogastroenterology & Motility. 2021:e14107.

  58. Bian Z, Wu T, Liu L, et al. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review. J Altern Complement Med. 2006;12(4):401–7.

    Article  PubMed  Google Scholar 

  59. Li D-y, Dai Y-k, Zhang Y-z, et al. Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome. PloS one. 2017;12(12):e0189491.

  60. Li J, Cui H, Cai Y, et al. Tong-Xie-Yao-Fang regulates 5-HT level in diarrhea predominant irritable bowel syndrome through gut microbiota modulation. Front Pharmacol. 2018;9:1110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Ma J, Pan J-y. Effect of Additional Tongxie Yaofang decoction on gastrointestinal hormone in patients with diarrhea-predomi nant IBS. Modern Journal of Intergerated Chinese Traditional and Western Medicine. 2007;16(21):2969.

  62. Leung WK, Wu JC, Liang S, et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial. Official journal of the American College of Gastroenterology| ACG. 2006;101(7):1574–1580.

  63. Kim J-H, Lee J-H, Jeong SM, et al. Effect of ginseng saponins on a rat visceral hypersensitivity model. Biol Pharm Bull. 2005;28(11):2120–4.

    Article  CAS  PubMed  Google Scholar 

  64. Shi J, Xu F, Song L, Mei S, Tao D, Wang H. Effect of xiaoyansan on 5-hydroxytryptamine receptors in rats with irritable bowel syndrome. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine. 2012;22(3):172–4.

    Google Scholar 

  65. Xu Z, Liu T, Zhou Q, Chen J, Yuan J, Yang Z. Roles of Chinese medicine and gut microbiota in chronic constipation. Evidence-Based Complementary and Alternative Medicine. 2019;2019.

  66. Cheng C-W, Bian Z-X, Zhu L-X, Wu JC, Sung JJ. Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation. Official journal of the American College of Gastroenterology| ACG. 2011;106(1):120–129.

  67. Bian Z, Cheng C, Zhu L. Chinese herbal medicine for functional constipation: a randomised controlled trial. Hong Kong medical journal= Xianggang yi xue za zhi. 2013;19:44–46.

  68. Huang C-H, Su Y-C, Li T-C, et al. Treatment of constipation in long-term care with Chinese herbal formula: a randomized, double-blind placebo-controlled trial. The Journal of Alternative and Complementary Medicine. 2011;17(7):639–46.

    Article  PubMed  Google Scholar 

  69. Wang X, Yin J. Complementary and alternative therapies for chronic constipation. Evidence-Based Complementary and Alternative Medicine. 2015;2015.

  70. Huang C-H, Lin J-S, Li T-C, et al. Comparison of a Chinese herbal medicine (CCH1) and lactulose as first-line treatment of constipation in long-term care: a randomized, double-blind, double-dummy, and placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine. 2012;2012.

  71. Gong H, Qin F, He H. Herbal formula modified buzhong-yiqi-tang for functional constipation in adults: a meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2018;2018.

  72. Yao Y-B, Cao Y-Q, Guo X-T, et al. Biofeedback therapy combined with traditional chinese medicine prescription improves the symptoms, surface myoelectricity, and anal canal pressure of the patients with spleen deficiency constipation. Evidence-Based Complementary and Alternative Medicine. 2013;2013.

  73. Huang T, Zhao L, Lin C-Y, et al. Chinese herbal medicine (MaZiRenWan) improves bowel movement in functional constipation through down-regulating oleamide. Front Pharmacol. 2020;10:1570.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Liu S, Sui D, Fu W, et al. Laxative effects of yangyin tongmi capsule on a model of diphenoxylate-induced constipation in mice. Evidence-Based Complementary and Alternative Medicine. 2020;2020.

  75. Xiao Y, Li Y, Shu J, et al. The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome. J Gastroenterol Hepatol. 2019;34(3):526–31.

    Article  CAS  PubMed  Google Scholar 

  76. Wen Y-D, Lu F, Zhao Y-P, et al. Epigastric pain syndrome: What can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules. World J Gastroenterol. 2020;26(28):4170.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Hu Y, Bai Y, Hua Z, et al. Effect of Chinese patent medicine Si-Mo-Tang oral liquid for functional dyspepsia: A systematic review and meta-analysis of randomized controlled trials. PloS one. 2017;12(2):e0171878.

  78. Wen M-y, Zhang F-c, Wang Y-j. Effect of Zhizhu Kuanzhong Capsules on Treatment of Functional Dyspepsia: A Meta-Analysis of Randomized Controlled Trials. Chin J Integr Med. 2019;25(8):625–30.

    Article  PubMed  Google Scholar 

  79. Ji E, Wang T, Guo F, et al. Xiaoerfupi alleviates the symptoms of functional dyspepsia by regulating the HTR3A and c-FOS. Biomedicine & Pharmacotherapy. 2019;120:109442.

  80. Shih Y-S, Tsai C-H, Li T-C, et al. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial. Phytomedicine. 2019;56:118–25.

    Article  PubMed  Google Scholar 

  81. Xiao J, Yang Y, Zhu Y, et al. Efficacy and safety of traditional chinese medicine on nonerosive reflux disease: a meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2018;2018.

  82. Jiang Z, Cao L-X, Liu B, et al. Effects of Chinese herbal medicine Xiangbin prescription on gastrointestinal motility. World J Gastroenterol. 2017;23(16):2987.

    Article  PubMed  PubMed Central  Google Scholar 

  83. GUO J, DOU J, LI R. Evaluation on therapeutic effect of needle warming moxibustion combined with Banxia-Xiexin decoction in diabetic gastroparesis. International Journal of Traditional Chinese Medicine. 2019:451–453.

  84. Tian J-X, Li M, Liao J-Q, Liu W-K, Tong X-L. Xiangshaliujunzi Decoction for the treatment of diabetic gastroparesis: a systematic review. World J Gastroenterol: WJG. 2014;20(2):561.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Nickles MA, Hasan A, Shakhbazova A, Wright S, Chambers CJ, Sivamani RK. Alternative treatment approaches to small intestinal bacterial overgrowth: a systematic review. The Journal of Alternative and Complementary Medicine. 2021;27(2):108–19.

    Article  PubMed  Google Scholar 

  86. Chedid V, Dhalla S, Clarke JO, et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Global Advances in Health and Medicine. 2014;3(3):16–24.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Jiang Z, Chen Q, Zhang J, Cao L, Chen Z. Wuda granule, a traditional Chinese herbal medicine, ameliorates postoperative ileus by anti-inflammatory action. Pathology-Research and Practice. 2020;216(3):152605.

  88. Shin SJ, Kim D, Kim JS, et al. Effects of Gamisoyo-San Decoction, a traditional Chinese medicine, on gastrointestinal motility. Digestion. 2018;98(4):231–7.

    Article  CAS  PubMed  Google Scholar 

  89. Liu S-H, Chuang W-C, Lam W, Jiang Z, Cheng Y-C. Safety surveillance of traditional Chinese medicine: current and future. Drug Saf. 2015;38(2):117–28.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Yang B, Xie Y, Guo M, Rosner MH, Yang H, Ronco C. Nephrotoxicity and Chinese herbal medicine. Clin J Am Soc Nephrol. 2018;13(10):1605–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Liu JP, Yang M, Liu Y, Wei ML, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews. 2006(1).

  92. Qin F, Huang X, Ren P. Chinese herbal medicine modified xiaoyao san for functional dyspepsia: Meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2009;24(8):1320–5.

    Article  CAS  PubMed  Google Scholar 

  93. Chao J, Dai Y, Verpoorte R, et al. Major achievements of evidence-based traditional Chinese medicine in treating major diseases. Biochem Pharmacol. 2017;139:94–104.

    Article  CAS  PubMed  Google Scholar 

  94. Huang Y, Yao P, Leung KW, et al. The Yin-Yang property of Chinese medicinal herbs relates to chemical composition but not anti-oxidative activity: an illustration using spleen-meridian herbs. Front Pharmacol. 2018;9:1304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology, Department of Pediatrics, UH Rainbow Babies & Children’s Hospital, Case Western Reserve University School of Medicine, Cleveland, OH, 44122, USA

    Senthilkumar Sankararaman, Sujithra Velayuthan, Youqin Chen & Thomas J. Sferra

  2. Seattle Institute of East Asian Medicine, 226 South Orcas Street, Seattle, WA, 98101, USA

    Jason Robertson

Authors
  1. Senthilkumar Sankararaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sujithra Velayuthan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Youqin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jason Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas J. Sferra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Senthilkumar Sankararaman.

Ethics declarations

Conflict of Interest

TJS is a case reviewer for Best Doctors, Inc.  All other authors have no conflicts to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sankararaman, S., Velayuthan, S., Chen, Y. et al. Role of Traditional Chinese Herbal Medicines in Functional Gastrointestinal and Motility Disorders. Curr Gastroenterol Rep 24, 43–51 (2022). https://doi.org/10.1007/s11894-022-00843-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-022-00843-8

Keywords

Search

Navigation